DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

87.30 -2.45 (-2.73%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LGND $87.30 -2.73%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.78
Previous Close $89.75
Daily Range $86.56 - $90.48
52-Week Range $41.99 - $90.48
Market Cap $1.7B
P/E Ratio 160.27
Dividend (Yield) $0.00 (0.0%)
Volume 457,708
Average Daily Volume 424,985
Current FY EPS $1.49

Sector

Healthcare

Industry

Drug Makers

Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website: http://www.ligand.com/

News & Commentary Rss Feed

3 Up and Coming Biotech Stocks to Watch

Too late to jump on the biotech bandwagon? Not with these 3 hot stocks.

Interesting LGND Put And Call Options For June 19th

Health Care Sector Update for 04/20/2015: CLDX, LGND, LLY

Ligand Announces Partner TG Therapeutics Shows Positive Pre-Clinical Data on IRAK4 Compounds

It's "hip" to be repaired: Viking Therapeutics refiles terms for $20 million IPO

Fr. Emmanuel Lemelson Discusses Apple's Economic Prospects , World Wrestling Entertainment's Financi

Fr. Emmanuel Lemelson Discusses Apple's Economic Prospects , World Wrestling Entertainment's Financial Condition And Other Issues

Ligand Pharmaceuticals: Biotech's Jack Of All Trades

Insider Trading Alert - TINY, OLED And LGND Traded By Insiders

1 Expensive Biotech Stock Worth Buying

It's expensive -- but this biotech stock still looks like a bargain.

Spectrum Pharmaceuticals' CE-melphalan Under Review - Analyst Blog

See More LGND News...

LGND's Top Competitors

LGND $87.30 (-2.73%)
Current stock: LGND
AMGN $162.38 (-3.29%)
Current stock: AMGN
GILD $102.94 (-0.73%)
Current stock: GILD
BIIB $389.27 (-3.10%)
Current stock: BIIB